Table 2 -.
Population at Risk on 1/1/2017 | Diabetes Status at end of 2017 |
||
---|---|---|---|
Diabetes | No Diabetes | ||
| |||
N
Sex, n (%) |
2,347,989 | 7,862 | 2,340,127 |
Male | 1,133,031 (48.3) | 4313 (54.9) | 1,128,718 (48.2) |
Female | 1,214,847 (51.7) | 3549 (45.1) | 1,211,298 (51.8) |
Other/Unknown | 111 (0.0) | 0 (0.0) | 111 (0.0) |
Age, years, mean (SD)
Age Categories, years, n (%) |
31.5 (7.5) | 36.8 (6.0) | 31.5 (7.5) |
Age 20–24 | 564,390 (24.0) | 400 (5.1) | 563,990 (24.1) |
Age 25–29 | 412,323 (17.6) | 611 (7.8) | 411,712 (17.6) |
Age 30–34 | 462,358 (19.7) | 1397 (17.8) | 460,961 (19.7) |
Age 35–39 | 467,922 (19.9) | 2234 (28.4) | 465,688 (19.9) |
Age 40–45 | 440,996 (18.8) | 3220 (41.0) | 437,776 (18.7) |
Race/Ethnicity, n (%) * | |||
Hispanic (regardless of race) | 812,462 (34.6) | 3882 (49.4) | 808,580 (34.6) |
White (non-Hispanic) | 780,012 (33.2) | 1381 (17.6) | 778,631 (33.3) |
Asian | 360,861 (15.4) | 1380 (17.6) | 359,481 (15.4) |
Black (non-Hispanic) | 164,205 (7.0) | 640 (8.1) | 163,565 (7.0) |
Other race/ethnicity/missing | 212,341 (9.0) | 579 (7.4) | 236,170 (10.1) |
BMI nearest to 1/1/17, mean ± SD
BMI, kg/m2, n (%) |
28.3 (6.72) | 37.0 (8.72) | 28.3 (6.69) |
BMI < 18.5 | 32,622 (1.4) | 7 (0.1) | 32,615 (1.4) |
BMI 18.5–24.9 | 648,209 (27.6) | 368 (4.7) | 647,841 (27.7) |
BMI 25–29.9 | 608,465 (25.9) | 1270 (16.2) | 607,195 (25.9) |
BMI 30–35.9 | 346,943 (14.8) | 1952 (24.8) | 344,991 (14.7) |
BMI 35+ | 277,797 (11.8) | 4233 (53.8) | 273,564 (11.7) |
Missing | 433,953 (18.5) | 32 (0.4) | 433,921 (18.5) |
Insurance type, n (%) | |||
Commercial | 2,055,397 (87.5) | 6961 (88.5) | 2,048,436 (87.5) |
Medicaid, Medicare or state-subsidized | 168,782 (7.2) | 647 (8.2) | 168,135 (7.2) |
Private pay or Self-funded | 74,984 (3.2) | 165 (2.1) | 74,819 (3.2) |
Other/Missing | 48,826 (2.1) | 89 (1.2) | 48737(2.1) |
Median household Income in census block, US$ mean ± SD
Median household income, US$, n (%) |
75,268 (31324) | 68,681 (28369) | 75,291 (31331) |
<$30,000 | 67,646 (2.9) | 280 (3.6) | 67,366 (2.9) |
$30–<50 K | 453,957 (19.3) | 2030 (25.8) | 451,927 (19.3) |
$50–<75 K | 768,813 (32.7) | 2756 (35.1) | 766,057 (32.7) |
$75 < 100 K | 567,747 (24.2) | 1666 (21.2) | 566,081 (24.2) |
$100 < 150 K | 423,688 (18.0) | 1006 (12.8) | 422,682 (18.1) |
$150,000+ | 51,197 (2.2) | 92 (1.2) | 51,105 (2.2) |
Missing | 14,941 (0.6) | 32 (0.4) | 14,909 (0.6) |
Diabetes Medication † | |||
No diabetes medications | − | 1936 (24.6) | − |
Insulin +/− other diabetes medication | − | 728 (9.3) | − |
Other non-insulin diabetes medication(s) | − | 5198 (66.1) | − |
Diabetes type based on majority of ICD-10-CM codes † | |||
Type 1 | − | 126 (1.6) | − |
Type 2 | − | 7710 (98.1) | − |
Other type or unknown‡ | − | 26 (0.3) | − |
Other race/ethnicity (% of total population) includes Multiple Race (1.4%), Pacific Islander (0.9%), “Other Race” (0.8%), and Native American (0.3%).
In the 365 days after diabetes diagnosis.
Of the 26 individuals categorized as other diabetes type or unknow, 9 individuals had >50% of their codes for diabetes types other than type 1 diabetes or type 2 diabetes, 12 had equal numbers of codes for type 1 diabetes and type 2 diabetes or type 2 diabetes and other diabetes type, and 5 had codes for three types of diabetes, none of which exceeded 50% of the ICD-10 codes.